Characterization of ternary complexes of meloxicam-HPβCD and PVP or L-arginine prepared by the spray-drying technique

Acta Pharmaceutica

Volumn 58, Issue 4, 2008, Pages 455-466

  El Maradny, Hoda A ^a   Mortada, Sana A ^a   Kamel, Ola A ^b   Hikal, Ahmed H ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Amriya Pharmaceutical Industry   (Egypt)

Author keywords

Hydroxypropyl cyclodextrin; L arginine; Meloxicam; Polyvinyl pyrrolidone; Spray drying technique

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ARGININE; MELOXICAM; POVIDONE;

ARTICLE; CHEMICAL INTERACTION; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; LIPOPHILICITY; PARAMETER; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPE; SPRAY DRYING; TABLET COMPRESSION; TECHNIQUE; WETTABILITY;

EID: 58149174055     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-008-0029-9     Document Type: Article

References (23)

1. J. Kang, V. Kumar, D. Yang, P. R. Chowdhury and R. J. Hohl, Cyclodextrin complexation: Influence on the solubility, stability and cytotoxicity of camptothecin, an antineoplastic agent, Eur. J. Pharm. Sci. 15 (2002) 163-170; DOI: 10.1016/s0928-0987(01)00214-7.
2. A. Miro, F. Quaglia, L. Giannini, B. Cappello and M. I. La Rotonda, Drug/cyclodextrin solid systems in desiging hydrophilic matrices: A strategy to modulate drug delivery rate, Curr. Drug Deliv. 3 (2006) 373-378; DOI: 10.2174/156720106778 558994.
3. T. Loftsson and M. Brewster, Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization, J. Pharm. Sci. 85 (1996) 1017-1025; DOI: 10.1021/js950534b.
4. S. Baboota and S. P. Agarwal, Inclusion complexation of meloxicam with β-cyclodextrin, Ind. J. Pharm. Sci. 64 (2002) 408-411.
5. T. Loftsson, Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water soluble polymers, Pharmazie 53 (1998) 733-740.
6. S. G. V. Kumar and D. N. Mishra, Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG, J. Pharm. Soc. Jpn. 126 (2006) 657-664; DOI: 10.1248/yakushi.126.657.
7. M. Jug and M. Lacan-Becirevic, Multicomponent complexes of piroxicam with cyclodextrins and hydroxy propyl methyl cellulose, Drug Dev. Ind. Pharm. 30 (2004) 1051-1060; DOI: 10.1081/DDC-200040245.
8. P. Mura, M. T. Faucci and G. P. Bettinetti, The influence of polyvinyl pyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrins, Am. Ass. Pharm. Sci. 13 (2001)187-194.
9. K. P. R. Chowdry and S. V. Srinivas, Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl-β-cyclodextrins, AAPS PharmSciTech. 7 (2006) Article 79; DOI: 10.1208/pt-070379.
10. L. Ribeiro, T. Loftsson, D. Ferreira and F. Veiga, Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta cyclodextrin binary and ternary complexes, Chem. Pharm. Bull. 51 (2003) 914-922; DOI: 10.1248/cpb.51.914.
11. P. Mura, F. Maestrelli and M. Cirri, Ternary systems of naproxen with hydroxypropyl-β-cyclodextrins and amino acids, Int. J. Pharm. 260 (2003) 293-302; DOI: 10.1016/S0378-5173(03)00265-5.
12. P. Mura, G. P. Bettinetti, M. Cirri, F. Maestrelli, M. Sorrenti and L. Catenacci, Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl beta-cyclodextrin ternary system, Eur. J. Pharm. Biopharm. 59 (2005) 99-106; DOI: 10.1016/j.ejpb.2004.05.005.
13. British Pharmacopoeia 2008, Vol. III, HSM, London 2008, pp. 2867.
14. T. Higuchi and K. A. Connors, Phase solubility techniques, Adv. Anal. Chem. Instrum. 4 (1965) 117-212.
15. P. Gupta and A. K. Bansal, Molecular interactions in celecoxib-PVP- meglumine amorphous system, J. Pharm. Pharmacol. 57 (2005) 303-310; DOI: 10.1211/0022357055597.
16. E. Redenti, L. Szente and J. Szejtli, Drug/cyclodextrin/hydroxy acid mutlicomponent systems. Properties and pharmaceutical applications, J. Pharm. Sci. 89 (2000) 1-8; DOI: 10.1002/(SICI)1520-6017(200001)89:1〈1: :AID-JPS1〉3.3.CO;2-N.
17. X. Liu, H. Lin, J. Thenmozhiyal, S. Chan and O. Paul, Inclusion of acitretin into cyclodextrins: Phase solubility, photostability and physicochemical characterization, J. Pharm. Sci. 92 (2003) 2449-2457; DOI: 10.1002/jps.10495.
18. S. Baboota, M. Dhaliwal and K. Kohli, Physicochemical characterization, in vitro dissolution behaviour and pharmacodynamics studies of refecoxib-cyclodextrin inclusion compounds preparation and properties of refecoxib hydroxypropyl beta-cyclodextrin inclusion complex, Am. Ass. Pharm. Sci. 2 (2004) 1-25.
19. L. P. Ruan, B. Y. Yu, G. M. Fu and D. Zhu, Improving the solubility of ampelopsin by solid dispersion and inclusion complexes, J. Pharm. Biomed. Anal. 38 (2005) 457-464; DOI: 10.1016/j.jpba.2005.01.030.
20. S. W. Jun, M. S. Kim, J. S. Kim, H. J. Park, S. Lee, Woo and S. J. Hwang, Preparation and characterization of simvastatin/hydroxypropyl β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm. 66 (2007) 413-421; DOI: 10.1016/j.ejpb.2006.11.013.
21. N. B. Naidu, K. P. Chowdary, K. V. Murthy, V. Satyanarayana, A. R. Hayman and G. Becket, Physicochemical characterization and dissolution properties of meloxicam cyclodextrin binary systems, J. Pharm. Biomed. Anal. 35 (2004) 75-86; DOI: 10.1016/j.jpba.2004.01.003.
22. C. P. Mora, M. Cirri, B. Allolio, F. Carli and P. Mura, Enhancement of dehydroepiandrosterone solubility and bioavailability and ternary complexation with α-cyclodextrin and glycine, J. Pharm. Sci. 92 (2003) 2177-2184; DOI: 10.1002/jps.10485.
23. D. Laveneziana, R. Speranza, P. Raulli and G. Paredi, Ibuprofene-arginine in the managment of pain, Clin. Drug Invest. 11 (1996) 1-7; DOI: 10.2165/00044011-199600111-00003.